BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 26172526)

  • 1. The Blockade of Vascular Endothelial Growth Factor C Effectively Inhibits Corneal Lymphangiogenesis and Promotes Allograft Survival.
    Yan H; Yuan J; Peng R; Wang T; Deng J; Li W; Ling S
    J Ocul Pharmacol Ther; 2015 Nov; 31(9):546-54. PubMed ID: 26172526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allograft survival enhancement using doxycycline in alkali-burned mouse corneas.
    Ling S; Li W; Liu L; Zhou H; Wang T; Ye H; Liang L; Yuan J
    Acta Ophthalmol; 2013 Aug; 91(5):e369-78. PubMed ID: 23387987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of vascular endothelial growth factor C in transplanted corneas.
    Ling S; Qi C; Li W; Xu J; Kuang W
    Curr Eye Res; 2009 Jul; 34(7):553-61. PubMed ID: 19899968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crucial role of corneal lymphangiogenesis for allograft rejection in alkali-burned cornea bed.
    Ling S; Qi C; Li W; Xu J; Kuang W
    Clin Exp Ophthalmol; 2009 Dec; 37(9):874-83. PubMed ID: 20092597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dynamic aspects of corneal lymphatic vessels after keratoplasty in rats].
    Ling SQ; Li WH; Liang LY; Xu JG; Kuang WH
    Zhonghua Yan Ke Za Zhi; 2012 Apr; 48(4):337-43. PubMed ID: 22800455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of vascular endothelial growth factor C and vascular endothelial growth factor receptor 3 in corneal lymphangiogenesis.
    Mimura T; Amano S; Usui T; Kaji Y; Oshika T; Ishii Y
    Exp Eye Res; 2001 Jan; 72(1):71-8. PubMed ID: 11133184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VEGF-trap aflibercept significantly improves long-term graft survival in high-risk corneal transplantation.
    Dohlman TH; Omoto M; Hua J; Stevenson W; Lee SM; Chauhan SK; Dana R
    Transplantation; 2015 Apr; 99(4):678-86. PubMed ID: 25606789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Promotion of graft survival by vascular endothelial growth factor a neutralization after high-risk corneal transplantation.
    Bachmann BO; Bock F; Wiegand SJ; Maruyama K; Dana MR; Kruse FE; Luetjen-Drecoll E; Cursiefen C
    Arch Ophthalmol; 2008 Jan; 126(1):71-7. PubMed ID: 18195221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking neuropilin-2 enhances corneal allograft survival by selectively inhibiting lymphangiogenesis on vascularized beds.
    Tang XL; Sun JF; Wang XY; Du LL; Liu P
    Mol Vis; 2010 Nov; 16():2354-61. PubMed ID: 21139694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical and experimental research of corneal lymphangiogenesis after keratoplasty.
    Ling S; Lin H; Xiang D; Feng G; Zhang X
    Ophthalmologica; 2008; 222(5):308-16. PubMed ID: 18617753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of new lymphatic vessels in alkali-burned corneas.
    Ling S; Lin H; Liang L; Xu J; Xu C; Zhao W; Liu Z
    Acta Ophthalmol; 2009 May; 87(3):315-22. PubMed ID: 18811642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of interleukin-12p40 gene transfer on rat corneal allograft survival.
    Ritter T; Yang J; Dannowski H; Vogt K; Volk HD; Pleyer U
    Transpl Immunol; 2007 Nov; 18(2):101-7. PubMed ID: 18005852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockade of insulin receptor substrate-1 inhibits corneal lymphangiogenesis.
    Hos D; Regenfuss B; Bock F; Onderka J; Cursiefen C
    Invest Ophthalmol Vis Sci; 2011 Jul; 52(8):5778-85. PubMed ID: 21666240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lymphangiogenesis occurring in transplanted corneas.
    Ling S; Qing X; Hu Y
    J Huazhong Univ Sci Technolog Med Sci; 2006; 26(2):241-4. PubMed ID: 16850758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The relationship between corneal lymphangiogenesis and inflammation index after corneal alkali injury].
    Ling SQ; Li WH; Xu JG; Kuang WH; Li CY
    Zhonghua Yan Ke Za Zhi; 2010 Nov; 46(11):1000-5. PubMed ID: 21211296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of Allograft Rejection with Soluble VEGF Receptor 2 Chimeric Protein in a Mouse Model of Corneal Transplantation.
    Hayashi T; Usui T; Yamagami S
    Tohoku J Exp Med; 2016 May; 239(1):81-8. PubMed ID: 27212075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble vascular endothelial growth factor receptor-3 suppresses allosensitization and promotes corneal allograft survival.
    Emami-Naeini P; Dohlman TH; Omoto M; Hattori T; Chen Y; Lee HS; Chauhan SK; Dana R
    Graefes Arch Clin Exp Ophthalmol; 2014 Nov; 252(11):1755-62. PubMed ID: 25091513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined blockade of VEGFR-3 and VLA-1 markedly promotes high-risk corneal transplant survival.
    Zhang H; Grimaldo S; Yuen D; Chen L
    Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6529-35. PubMed ID: 21715348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory corneal (lymph)angiogenesis is blocked by VEGFR-tyrosine kinase inhibitor ZK 261991, resulting in improved graft survival after corneal transplantation.
    Hos D; Bock F; Dietrich T; Onderka J; Kruse FE; Thierauch KH; Cursiefen C
    Invest Ophthalmol Vis Sci; 2008 May; 49(5):1836-42. PubMed ID: 18436817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Lymphangiogenic Markers in Rejected Human Corneal Buttons after Penetrating Keratoplasty.
    Seo Y; Kim MK; Lee JH; Chang EJ; Kim EK; Lee HK
    Curr Eye Res; 2015 Sep; 40(9):902-12. PubMed ID: 25330436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.